Logo: to the web site of Uppsala University

uu.sePublications from Uppsala University
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
A beta and tau prions feature in the neuropathogenesis of Down syndrome
Univ Calif San Francisco, Weill Inst Neurosci, Inst Neurodegenerat Dis, San Francisco, CA 94158 USA.;Univ Calif San Francisco, Weill Inst Neurosci, Depat Neurol, San Francisco, CA 94158 USA..
Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA..
Univ Calif San Francisco, Weill Inst Neurosci, Inst Neurodegenerat Dis, San Francisco, CA 94158 USA..ORCID iD: 0000-0003-2492-901X
Univ Calif San Francisco, Weill Inst Neurosci, Inst Neurodegenerat Dis, San Francisco, CA 94158 USA.;Daiichi Sankyo Co Ltd, Tokyo 1038426, Japan..
Show others and affiliations
2022 (English)In: Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, E-ISSN 1091-6490, Vol. 119, no 46, article id e2212954119Article in journal (Refereed) Published
Abstract [en]

Down syndrome (DS) is caused by the triplication of chromosome 21 and is the most common chromosomal disorder in humans. Those individuals with DS who live beyond age 40 y develop a progressive dementia that is similar to Alzheimer's disease (AD). Both DS and AD brains exhibit numerous extracellular amyloid plaques composed of A beta and intracellular neurofibrillary tangles composed of tau. Since AD is a double-prion disorder, we asked if both A beta and tau prions feature in DS. Frozen brains from people with DS, familial AD (fAD), sporadic AD (sAD), and age-matched controls were procured from brain biorepositories. We selectively precipitated A beta and tau prions from DS brain homogenates and measured the number of prions using cellular bioassays. In brain extracts from 28 deceased donors with DS, ranging in age from 19 to 65 y, we found nearly all DS brains had readily measurable levels of A beta and tau prions. In a cross-sectional analysis of DS donor age at death, we found that the levels of A beta and tau prions increased with age. In contrast to DS brains, the levels of A beta and tau prions in the brains of 37 fAD and sAD donors decreased as a function of age at death. Whether DS is an ideal model for assessing the efficacy of putative AD therapeutics remains to be determined.

Place, publisher, year, edition, pages
Proceedings of the National Academy of Sciences Proceedings of the National Academy of Sciences (PNAS), 2022. Vol. 119, no 46, article id e2212954119
Keywords [en]
Down syndrome, A beta, tau, prions, cellular bioassays
National Category
Neurosciences
Identifiers
URN: urn:nbn:se:uu:diva-502682DOI: 10.1073/pnas.2212954119ISI: 000980665600003PubMedID: 36343257OAI: oai:DiVA.org:uu-502682DiVA, id: diva2:1759956
Funder
Swedish Research CouncilAvailable from: 2023-05-29 Created: 2023-05-29 Last updated: 2024-12-03Bibliographically approved

Open Access in DiVA

No full text in DiVA

Other links

Publisher's full textPubMed

Authority records

Ingelsson, MartinLannfelt, Lars

Search in DiVA

By author/editor
Castillo, ErikaIngelsson, MartinLannfelt, Lars
By organisation
Geriatrics
In the same journal
Proceedings of the National Academy of Sciences of the United States of America
Neurosciences

Search outside of DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 56 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf